Vous êtes sur la page 1sur 1

Clinical Medications Worksheets

Generic Name Trade Name Classification Dose Route Time/frequency


linezolid Zyvox anti-infectives, 600mg IV Q 12 hrs
oxazolidinones
Peak Onset Duration Normal dosage range
End of infusion Rapid 12 hr 600 mg every 12 hr for 14-28 days
RATE: Administer over 30-120 minutes.
Why is your patient getting this medication For IV meds, compatibility with IV drips and/or solutions
Complicated skin/skin structure infections caused by Do not piggyback into other IV lines. Flush line before and after
Staphylococcus aureus (methicillin-susceptible and -resistant infusion.
strains), Uncomplicated skin/skin structure infections caused Y-Site Incompatibility: amphotericin B, chlorpromazine, diazepam,
by Staphylococcus aureus (methicillin-susceptible and pentamidine, phenytoin
-resistant strains)
Mechanism of action and indications Nursing Implications (what to focus on)
(Why med ordered) Contraindications/warnings/interactions
Inhibits bacterial protein synthesis at the level of the 23S Hypersensitivity
ribosome of the 50S subunit. Bactericidal action against
streptococci; bacteriostatic action against enterococci and
Common side effects
staphylococci.
PSEUDOMEMBRANOUS COLITIS
Interactions with other patient drugs, OTC or herbal Lab value alterations caused by medicine
medicines (ask patient specifically) May cause bone marrow suppression, anemia, leukopenia,
Xopenex: Patients should be closely monitored for blood pancytopenia. Monitor CBC and platelet count weekly, especially in
pressure and pulse rate changes during coadministration of patients who are at risk for increased bleeding, who have pre-existing
beta-adrenergic agonists with MAOIs or other agents that bone marrow suppression, who receive concurrent medications that
possess MAOI activity (e.g., furazolidone, linezolid, may cause myelosuppression, or who may require >2 weeks of therapy.
procarbazine). Preferably, at least 14 days should elapse Discontinue therapy if bone marrow suppression occurs or worsens.
between discontinuation of MAOI therapy and initiation of May cause ↑ AST, ALT, LDH, alkaline phosphatase and BUN
treatment with beta-adrenergic agonists.
Because of monoamine oxidase inhibitory properties,
consumption of large amounts of foods or beverages
containing tyramine should be avoided (↑ risk of pressor
response.) Be sure to teach the patient the following about this medication
Advise patients taking oral linezolid to take as directed, for full course
of therapy, even if feeling better. Take missed doses as soon as
remembered unless almost time for next dose; do not double dose.
Instruct patient to avoid large quantities of foods or beverages
containing tyramine (May cause hypertensive response). Instruct
patient to notify health care professional if patient has a history of
hypertension and before patient takes other Rx, OTC, or herbal
products, especially cold remedies, decongestants, or antidepressants.
Advise patient to notify health care professional if no improvement is
seen in a few days.
Nursing Process- Assessment Assessment Evaluation
(Pre-administration assessment) Why would you hold or not give this med? Check after giving
Assess for infection (vital signs; appearance of recurrent nausea and vomiting, unexplained Improvement of infection
wound, sputum, urine, and stool; WBC) at acidosis or low bicarbonate levels. If optic
beginning of and during therapy. Obtain neuropathy occurs therapy should be
specimens for culture and sensitivity prior to reconsidered
initiating therapy. First dose may be given before
receiving

Vous aimerez peut-être aussi